Evidence map›Paper›PMID 22290238›Full record

ReviewNature reviews. Cardiology2012

Potassium-channel mutations and cardiac arrhythmias--diagnosis and therapy.

John R Giudicessi, Michael J Ackerman

Open access · greenAbstract readReview
In one paragraph

Review in Nature reviews. Cardiology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 99 citations in OpenAlex.

  1. Article
  2. Primary aldosteronism.Nature reviews. Disease primers · 2026
    Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

John R GiudicessiMayo Medical School, Mitchell Student Center BA-07, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.
Michael J Ackerman
Mayo Clinic · US

Funding

RYANODINE RECEPTORS, Ca2+-TRIGGERED ARRHYTHMIAS AND HCMP01HL094291 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI MOSS, RICHARD L · 2009 to 2013
$9.7M
Cardiac Channel Mutations in Sudden Infant Death Syndrome (SIDS)R01HD042569 · NICHD · MAYO CLINIC ROCHESTER · PI ACKERMAN, MICHAEL JOHN · 2002 to 2017
$6.9M
The Role of The Transient Outward Current In Genetically Elusive Sudden DeathF30HL106993 · NHLBI · MAYO CLINIC ROCHESTER · PI GIUDICESSI, JOHN R. · 2011 to 2014
$134k
NHLBI NIH HHS F30 HL106993NHLBI NIH HHS F30‑HL106993NHLBI NIH HHS P01 HL094291NHLBI NIH HHS P01‑HL094291NICHD NIH HHS R01 HD042569NICHD NIH HHS R01‑HD42569
6 · The paper itself

Abstract

The coordinated generation and propagation of action potentials within cardiomyocytes creates the intrinsic electrical stimuli that are responsible for maintaining the electromechanical pump function of the human heart. The synchronous opening and closing of cardiac Na(+), Ca(2+), and K(+) channels corresponds with the activation and inactivation of inward depolarizing (Na(+) and Ca(2+)) and outward repolarizing (K(+)) currents that underlie the various phases of the cardiac action potential (resting, depolarization, plateau, and repolarization). Inherited mutations in pore-forming α subunits and accessory β subunits of cardiac K(+) channels can perturb the atrial and ventricular action potential and cause various cardiac arrhythmia syndromes, including long QT syndrome, short QT syndrome, Brugada syndrome, and familial atrial fibrillation. In this Review, we summarize the current understanding of the molecular and cellular mechanisms that underlie K(+)-channel-mediated arrhythmia syndromes. We also describe translational advances that have led to the emerging role of genetic testing and genotype-specific therapy in the diagnosis and clinical management of individuals who harbor pathogenic mutations in genes that encode α or β subunits of cardiac K(+) channels.

Indexed as

MutationAction PotentialsAnimalsArrhythmias, CardiacElectrocardiographyGenetic Predisposition to DiseaseGenetic TestingHumansPatient SelectionPhenotypePotassium ChannelsPrecision MedicinePredictive Value of TestsPrognosisRisk AssessmentRisk FactorsPotassium Channels

Identifiers

PMID22290238
PMCPMC6590894
OpenAlexW2020986777

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.